xanthinol niacinate has been researched along with Hyperchylomicronemia Late Onset in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haacke, H; Mäder, C; Parwaresch, MR | 1 |
| Ditschuneit, H; Hutt, V; Klör, HU; Wechsler, JG | 1 |
2 other study(ies) available for xanthinol niacinate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Serum profile of non-esterified fatty acids (NEFA) in patients with hyperlipoproteinemia under xantinol--nicotinate (XN) medication.
Topics: Adolescent; Adult; Aged; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipids; Middle Aged; Theophylline; Xanthinol Niacinate | 1980 |
Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Inositol; Lipoproteins; Nicotinic Acids; Xanthinol Niacinate | 1980 |